Branched Learning Curriculum in Rheumatic Disease


Branched Learning Curriculum in Rheumatic Disease

Topic: Rheumatology
Relevant Terms: Rheumatic Diseases, Gout, Ankylosing Spondylitis, Chronic Pain, Pain Management, Rheumatoid Arthritis, Psoriatic Arthritis
Primary Audience: Primary Care Physicians, Rheumatologists, Rheumatology Nurses
Launch Date: 08-Jan-13
Credits: AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. List unique symptoms of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis, and ankylosing spondylitis that may be used during the differential diagnosis of individual patients
  2. Explain the rationale behind the use of specific therapeutic targets in the management of newly diagnosed RA patients with low, medium, and high disease activity levels
  3. Assess the clinical applicability of recently published and presented comparative effectiveness data regarding biologic therapies in RA


    Neal Birnbaum, MD, FACP, MACR
    Director, Division of Rheumatology
    California Pacific Medical Center
    San Francisco, CA
    Instructions on How to Receive Credit
    • Participants must review the materials on accreditation information, target audience, learning objectives, and disclosure information. 
    • Complete the pre/post-test and evaluation 
    • After passing the post-test, print out your electronic CE certificate 
    • In order to successfully complete this activity, learners must achieve a minimum of 65% on the post-test.

    This activity is supported by an unrestricted educational grant from Genentech, Inc.
    This activity is sponsored by the Institute for Continuing Healthcare Education.

    Release Date: January 8, 2013
    Expiration Date: January 8, 2014

    Accreditation Statement
    The Institute for Continuing Healthcare Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The Institute for Continuing Healthcare Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Relationships are abbreviated as follows: E, Educational Planning Committee; G, Grant/research support recipient; A, Advisor/review panel member/educational planning committee; C, Consultant/Independent Contractor; SS, Stock shareholder; SB, Speaker bureau; PE, Promotional Event Talks; H, Honoraria; O, Other.

    Neal S. Birnbaum, MD, has disclosed the following relevant financial relationships in the past 12 months: Janssen, Amgen, Pfizer & Abbott/PE.

    Medical Writer
    Nick Sidorovich, no relationship to disclose

    Peer Reviewer
    Stanford Peng, MD,
    no relationship to disclose

    Activity Development and Management Team
    Cathy Pagano, CCMEPAllison A. Muller, Pharm.D, D.ABAT;  Scott Kober, MBA, CCMEPApril Reynolds, MS, ELSSandra Davidson; and Tina Chiu, MEd are employees of the Institute and have no relationships to disclose.
    Off-label Product Disclosure
    This educational activity includes discussion of published and/or investigational uses of agents that are not indicated by the U.S. Food and Drug Administration. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Safari 4.0+ for Mac
    For additional technical support, please send an email to 

    General Disclosure and Copyright Statement
    The opinions expressed in this publication are those of the participating faculty and not those of the Institute for Continuing Healthcare Education (the Institute), Genentech Inc., or any manufacturers of products mentioned herein.

    This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a healthcare professional regarding diagnostic and treatment options of a specific patient's medical condition. In no event will the Institute be responsible for any decision made or action taken based upon the information provided in this activity.

    Participants are encouraged to consult the package insert for all products for updated information and changes regarding indications, dosages, and contraindications. This recommendation is particularly important for new or infrequently used products.

    Copyright 2013. Institute for Continuing Healthcare Education (the Institute). All rights reserved. No part of this publication may be reproduced or transmitted in any other form or by any means electronic or mechanical—without first obtaining written permission from the Institute.

    The Institute reserves the right to cancel or modify the activity content, faculty, and activities if necessary.